Screening of Novel Inhibitors Targeting Human Papillomavirus 16 E6/Ap/P53 Ternary Complex Towards Development of Therapeutic Strategies Against HPV-mediated Oncogenesis

Canadian Journal of Biotechnology
doi 10.24870/cjb.2017-a43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Science Planet Inc.

Related search

PDZRN3/LNX3 Is a Novel Target of Human Papillomavirus Type 16 (HPV-16) and HPV-18 E6

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2014English

Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach

The Open Virology Journal
2012English

Human Papillomavirus (HPV) 16 E6 Seropositivity Is Elevated in Subjects With Oral HPV16 Infection

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2016English

The ING4 Binding With P53 and Induced P53 Acetylation Were Attenuated by Human Papillomavirus 16 E6

PLoS ONE
Multidisciplinary
2013English

Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections With Single and Multiple Genotypes

Cancer Prevention Research
MedicineCancer ResearchOncology
2019English

Cloning and Expression of the cDNA for E6-Ap, a Protein That Mediates the Interaction of the Human Papillomavirus E6 Oncoprotein With P53.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1993English

Antibodies Against Human Papillomavirus Type 16 (HPV-16) and Conjunctival Squamous Cell Neoplasia in Uganda

British Journal of Cancer
Cancer ResearchOncology
2003English

A Novel Intracellular Antibody Against the E6 Oncoprotein Impairs Growth of Human Papillomavirus 16-Positive Tumor Cells in Mouse Models

Oncotarget
Oncology
2016English

Complexes of Human Papillomavirus Type 16 E6 Proteins Form Pseudo-Death-Inducing Signaling Complex Structures During Tumor Necrosis Factor-Mediated Apoptosis

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy